SOURCE: Forum for Corporate Directors

Forum for Corporate Directors

November 24, 2009 15:37 ET

Allergan's Chairman and CEO to Address Strategic and Governance Issues Facing U.S. Companies With Global Operations at December Event Hosted by Forum for Corporate Directors

NEWPORT BEACH, CA--(Marketwire - November 24, 2009) - The Forum for Corporate Directors is featuring David Pyott, chairman of the board and chief executive officer of Allergan, at a meeting on Thursday, Dec. 3, 2009, during which Mr. Pyott will discuss Allergan's success as a leading healthcare company doing business internationally while also addressing the current challenges and opportunities that U.S. companies face as global businesses. Allergan has approximately 8,500 employees located in 24 countries and with sales in more than 100 countries.

According to John Della Grotta, chair of FCD and a partner at Paul, Hastings, Janofsky & Walker LLP, with the increased globalization of the economy, understanding how to manage effectively key aspects of doing business internationally is increasingly important to many Orange County companies. Among the issues Mr. Pyott will address at the meeting are: 1) the governance issues faced by the board of directors of a global business; 2) the level of autonomy given to Allergan's foreign subsidiaries; 3) recent SEC vigilance related to the Foreign Corrupt Practices Act and the need for policies and training for companies with international operations; and 4) likely topics in the coming proxy season such as say-on-pay and proxy access.

"David Pyott leads one of the country's most respected and successful public healthcare companies headquartered in Orange County but with presence throughout the world. His more than 25 years of international experience gives him a real world perspective on the key issues public companies need to be aware of as they pursue expansion of their businesses into international markets," Della Grotta said.

Mr. Pyott was recognized by Institutional Investor magazine in 2005 and 2007 as one of the top CEOs in the country. In recent years, Allergan has been ranked by Wall Street as one of the "Most Shareholder-Friendly Companies" in its industry.

For more information about the FCD meeting with David Pyott on Thursday, December 3, 2009, to be held at the Island Hotel in Newport Beach, and to register for this event, please visit the Forum for Corporate Directors website at www.fcdoc.org.

About the Forum for Corporate Directors

Founded in 1991, the Forum for Corporate Directors is a non-profit organization established to help directors, C-Level executives and others who support boards set the highest standards in corporate governance through peer relationships, education and thought leadership. FCD members include many of Southern California's top business and corporate leaders. Corporate members include Abbott Medical Optics; Alacer Corp.; California State University Fullerton Mihaylo College of Business & Economics; Conexant Systems, Inc; DDI Corp.; Emulex Corporation; George L. Argyros School of Business & Economics at Chapman University; Local.com; MFLEX; Microsemi Corporation; National Technical Systems; Powerwave Technologies; QLogic Corporation; Quality Systems Inc.; RealtyTrac, Inc.; Resources Global Professionals; SRS Labs, Inc.; and The Paul Merage School of Business at UC Irvine.

About Allergan, Inc.

Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential -- to see more clearly, move more freely, express themselves more fully. The Company employs more than 8,500 people worldwide and operates state-of-the-art R&D facilities and world-class manufacturing plants. In addition to its discovery-to-development research organization, Allergan has global marketing and sales capabilities with a presence in more than 100 countries.

Contact Information

  • Media Contact:
    Connie Chandler
    IR Strategies
    714-573-1115
    Email Contact